Muna Therapeutics Funding: $73M Raised, Series A (2021)
Muna Therapeutics is based in Copenhagen, Denmark. It has raised $73M in total funding. Latest round: Series A.
Muna Therapeutics funding overview
Muna Therapeutics is based in Copenhagen, Denmark. Muna Therapeutics has raised $73M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in July 2021. The round record for Muna Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Novo Holdings, Sofinnova Partners, Droia Ventures, LSP Dementia Fund, Polaris Partners, Polaris Innovation Fund and 3 others. 9 distinct backers are named across the disclosed rounds.
Muna Therapeutics has raised $73M in total disclosed funding across the rounds on record.
Who has invested in Muna Therapeutics?
Novo Holdings, Sofinnova Partners, Droia Ventures, LSP Dementia Fund, Polaris Partners, Polaris Innovation Fund are named among the investors backing Muna Therapeutics.
What was the latest Muna Therapeutics funding round?
The most recent disclosed round is a Series A, announced in July 2021.
Where is Muna Therapeutics based?
Muna Therapeutics is based in Copenhagen, Denmark.
When did Muna Therapeutics last raise?
The last disclosed Muna Therapeutics round closed in July 2021 at Series A.
Round data for Muna Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Copenhagen and backer lists below.
